DIA: Driving Insights to Action
Science:Life Sciences
iOS
AndroidMore Episodes
DIAmond Session 302: Europe and the US: Making Outcomes-Based Health Care Possible
2016-12-13
94
DIAmond Session 203: “Innovation is Clearly Happening”: Next Generation Collaboration: Transforming the Industry
2016-12-13
115
DIAmond Session 201: International Regulatory Convergence, Collaboration & Cooperation
2016-12-13
99
Executive FDA Leadership Reviews & Previews PDUFA Reauthorization
2016-10-18
182
“Biosimilars have at last come of age in the United States”
2016-10-13
135
Mission, History & Opportunity Attracts New DIA Americas Leadership
2016-10-13
97
Clinical & Real-World Data: Is AI the Missing Link?
2016-10-07
178
TransCelerate Moves Clinical QMS from Vision to Conceptual Framework
2016-07-13
552
Executive Director Shares New CTTI Strategic Plan to Improve Clinical Trials
2016-07-07
150
Who Determines the Price of Medicines – and How?
2016-06-21
173
“An Urgent Imperative Now to Learn Quickly”: DIA 2016 Co-Chair Dr. Gigi Hirsch
2016-06-17
169
Industry-Patient Relations: Culture Change or Culture Shock?
2016-06-14
180
Every Journey Begins with a First Step: DIA Patient Engagement
2016-06-02
147
“Outbreaks are inevitable. Pandemics are preventable.” – DIA 2016 Keynote Speaker Dr. Larry Brilliant
2016-05-25
159
Growing Irrelevancy of Pre- versus Post-Market Divide for EU Medical Devices
2016-04-27
193
Crossroads in Europe: Access from a Market and HTA Perspective
2016-04-27
130
A Visionary Takes the Helm at DIA Europe, Middle East & Africa (DIA EMEA)
2016-04-26
105
Steps to Meet the “Big Quality” Challenge of “Big Data”
2016-04-25
127
Innovation: Can it Span the “Efficacy versus Effectiveness Gap”?
2016-04-22
156
Dr. Kemal Malik Ponders “Is Innovation Always the Answer?”
2016-04-22
134
